Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedApr 26, 2025
DataAggregated Company Financials
Companies216
  • 7D-0.7%
  • 3M-12.0%
  • 1Y-12.3%
  • YTD-9.2%

The Healthcare is pretty flat in the last 7 days, but Sunmax Biotechnology has stood out, gaining 8.5%. As for the longer term, the industry has declined 12% in the last year. Looking forward, earnings are forecast to grow by 49% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 27 Apr 2025NT$1.4tNT$254.5bNT$12.1b19.7x112.9x5.4x
Tue, 25 Mar 2025NT$1.6tNT$254.1bNT$11.7b21.8x137.9x6.3x
Thu, 20 Feb 2025NT$1.7tNT$246.5bNT$8.4b23.4x200.3x6.9x
Sat, 18 Jan 2025NT$1.5tNT$245.2bNT$8.6b22x177x6.2x
Mon, 16 Dec 2024NT$1.5tNT$245.0bNT$8.6b21.9x169.3x6x
Wed, 13 Nov 2024NT$1.5tNT$238.4bNT$7.7b23.3x196.6x6.4x
Fri, 11 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.7x227.6x6.5x
Sun, 08 Sep 2024NT$1.6tNT$236.4bNT$6.8b25.1x232.7x6.7x
Tue, 06 Aug 2024NT$1.5tNT$229.1bNT$3.5b26.2x417.5x6.4x
Thu, 04 Jul 2024NT$1.7tNT$228.8bNT$3.6b29.4x467.6x7.3x
Sat, 01 Jun 2024NT$1.5tNT$228.6bNT$3.9b26x382x6.5x
Mon, 29 Apr 2024NT$1.4tNT$228.8bNT$4.3b25.4x336x6.2x
Wed, 27 Mar 2024NT$1.4tNT$228.8bNT$7.2b25.4x198.2x6.3x
Fri, 23 Feb 2024NT$1.5tNT$225.8bNT$6.5b25.4x225.1x6.4x
Sun, 21 Jan 2024NT$1.4tNT$224.9bNT$6.0b24.5x231.6x6.2x
Tue, 19 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.5x241.1x6.3x
Thu, 16 Nov 2023NT$1.4tNT$224.0bNT$7.0b24.7x196.2x6.2x
Sat, 14 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.9x162.9x6x
Mon, 11 Sep 2023NT$1.4tNT$225.2bNT$8.4b25.5x163.7x6.1x
Wed, 09 Aug 2023NT$1.4tNT$226.6bNT$11.4b26.2x121.8x6.1x
Fri, 07 Jul 2023NT$1.4tNT$226.5bNT$11.6b25.9x125.4x6.4x
Sun, 04 Jun 2023NT$1.4tNT$225.6bNT$12.9b24x111.5x6.4x
Tue, 02 May 2023NT$1.4tNT$220.1bNT$12.0b23.6x120.1x6.6x
Thu, 30 Mar 2023NT$1.4tNT$220.6bNT$12.3b21.1x116.4x6.5x
Sat, 25 Feb 2023NT$1.4tNT$214.5bNT$13.6b21.5x106.5x6.7x
Mon, 23 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Wed, 21 Dec 2022NT$1.3tNT$214.5bNT$14.1b20.1x90.5x6x
Fri, 18 Nov 2022NT$1.2tNT$215.3bNT$15.5b17.7x80.3x5.8x
Sun, 16 Oct 2022NT$1.2tNT$207.4bNT$10.8b19x109.4x5.7x
Tue, 13 Sep 2022NT$1.4tNT$207.4bNT$10.7b21.7x133.4x6.9x
Thu, 11 Aug 2022NT$1.2tNT$200.4bNT$10.3b21x120.7x6.2x
Sat, 09 Jul 2022NT$1.2tNT$199.0bNT$9.8b22x121.1x5.9x
Mon, 06 Jun 2022NT$1.2tNT$207.9bNT$10.7b21.9x112x5.8x
Wed, 04 May 2022NT$1.2tNT$206.2bNT$12.2b22.4x102x6.1x
Price to Earnings Ratio

102x


Total Market Cap: NT$1.2tTotal Earnings: NT$12.2bTotal Revenue: NT$206.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 181x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 113x which is lower than its 3-year average PE of 181x.
  • The 3-year average PS ratio of 6.3x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 7.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market2.42%
Healthcare-0.73%
Pharma-0.21%
Biotech-0.28%
Healthtech-0.33%
Life Sciences-1.48%
Healthcare Services-1.86%
Medical Equipment-2.33%
Industry PE
  • Investors are most optimistic about the Healthtech industry, which is trading close to its 3-year average PE ratio of 196x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 54% over the next 5 years.
  • This is better than its past earnings growth rate of 13% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4728 Sunmax BiotechnologyNT$448.008.5%
+NT$1.9b		98.7%PE35.9x
7759 Sunhawk Vision BiotechNT$109.5018.9%
+NT$1.2b		n/an/a
6976 AcepodiaNT$17.8010.6%
+NT$986.9m		-36.2%PS24199.1x
4771 VizionfocusNT$193.507.8%
+NT$812.2m		-37.0%PE16.8x
6875 Pharmosa BiopharmNT$51.6011.0%
+NT$658.3m		-20.0%PS39.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4174

NT$38.00

OBI Pharma

7D

-19.1%

1Y

-35.6%

6875

NT$51.60

Pharmosa Biopharm

7D

11.0%

1Y

-20.0%

6472

NT$684.00

Bora Pharmaceuticals

7D

0.7%

1Y

-9.0%

4104

NT$84.60

Excelsior Medical

7D

-4.5%

1Y

-3.0%

4728

NT$448.00

Sunmax Biotechnology

7D

8.5%

1Y

98.7%

6550

NT$37.45

Polaris Group

7D

-1.4%

1Y

-43.0%

6541

NT$61.00

Tanvex BioPharma

7D

-2.9%

1Y

27.1%

4771

NT$193.50

Vizionfocus

7D

7.8%

1Y

-37.0%

6976

NT$17.80

Acepodia

7D

10.6%

1Y

-36.2%

6589

NT$61.30

EirGenix

7D

-2.7%

1Y

-22.1%

7799

NT$343.00

Heron Neutron Medical

7D

-10.7%

1Y

n/a

4147

NT$80.00

TaiMed Biologics

7D

2.6%

1Y

-3.6%

7759

NT$109.50

Sunhawk Vision Biotech

7D

18.9%

1Y

n/a

6586

NT$42.75

CHO Pharma

7D

-5.9%

1Y

-22.6%

6932

NT$13.80

Mercury Biopharmaceutical

7D

10.8%

1Y

-9.8%

6919

NT$612.00

Caliway Biopharmaceuticals

7D

-4.2%

1Y

56.3%